Sign-in to Ask A Doctor - 24x7
OR
Sign in with Google
In A Patient With Myelodysplastic Syndrome , Is Management The
Question: In a patient with myelodysplastic syndrome, is management the same with a platelet count of 1.41 million vs 1.15 million? Any treatment differences?
Brief Answer:
No there should not be
Detailed Answer:
Hi
Thanks for your query.
Platelet count of >100,000/uL is sufficient, even in MDS patient, so 140,000 or 115,000 won't make any difference to treatment.
Hope this helps.
Regards
No there should not be
Detailed Answer:
Hi
Thanks for your query.
Platelet count of >100,000/uL is sufficient, even in MDS patient, so 140,000 or 115,000 won't make any difference to treatment.
Hope this helps.
Regards
Above answer was peer-reviewed by :
Dr. Kampana
This is thromcytosis. These platelet counts are over 1 million. Do they both need to be lowered using hydroxyurea and aspirin or would the higher one have a different treatment than the lower one?
Brief Answer:
Aspirin should be enough
Detailed Answer:
MDS patients rarely have such high platelets but possible. These patients don't have much excess bleeding or thrombosis risk. So Aspirin alone should be enough for both patients.
But there is no clear guideline on managing platelet count in these patients.
Rest of MDS management as per risk group should continue.
Regards
Aspirin should be enough
Detailed Answer:
MDS patients rarely have such high platelets but possible. These patients don't have much excess bleeding or thrombosis risk. So Aspirin alone should be enough for both patients.
But there is no clear guideline on managing platelet count in these patients.
Rest of MDS management as per risk group should continue.
Regards
Note: Do you have more questions on diagnosis or treatment of blood disorders? Ask An Expert/ Specialist Now
Above answer was peer-reviewed by :
Dr. Yogesh D
Answered by
Get personalised answers from verified doctor in minutes across 80+ specialties
